DMK Pharmaceuticals Corporation (DMKPQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 4.75 Million | 2.2 Million | 2.77 Million | 22.11 Million | 15.08 Million | 13.07 Million |
| Cost of Revenue | 7.65 Million | 6.87 Million | 6.32 Million | 15.67 Million | 12.89 Million | 10.48 Million |
| Gross Profit | -2.89 Million | -4.66 Million | -3.55 Million | 6.43 Million | 2.18 Million | 2.58 Million |
| Operating Expenses | 22.16 Million | 27.4 Million | 28.12 Million | 36.43 Million | 42.54 Million | 27.28 Million |
| Selling, General and Administrative Expenses | 11.78 Million | 16.14 Million | 20.08 Million | 25.08 Million | 22.84 Million | 19.75 Million |
| Research and Development Expenses | 10.37 Million | 11.26 Million | 8.03 Million | 11.02 Million | 19.69 Million | 7.52 Million |
| Other Expenses | - | 7216.00 | 38.31 Thousand | -322.11 Thousand | - | - |
| Cost and Expenses | 29.81 Million | 34.27 Million | 34.45 Million | 52.11 Million | 55.43 Million | 37.76 Million |
| Operating Income | -25.05 Million | -32.06 Million | -31.67 Million | -30 Million | -40.35 Million | -24.69 Million |
| Interest Expense | - | 6649.00 | 4921.00 | 123.25 Thousand | 157.76 Thousand | 231.29 Thousand |
| Income Tax Expense | 2000.00 | 796.00 | 2400.00 | -643.32 Thousand | -1.26 Million | -339.39 Thousand |
| Earnings before Tax | -26.19 Million | -34.59 Million | -35.84 Million | -28.15 Million | -40.27 Million | -25.87 Million |
| Net Income | -26.47 Million | -45.82 Million | -49.39 Million | -27.51 Million | -39 Million | -25.53 Million |
| Earnings Per Share Basic | -12.37 | -22.25 | -44.57 | -36.16 | -69.86 | -63.06 |
| Earnings Per Share Diluted | -12.37 | -22.25 | -44.57 | -36.16 | -69.86 | -63.06 |
| Weighted Average Shares Outstanding | 2.14 Million | 2.05 Million | 1.1 Million | 760.91 Thousand | 558.36 Thousand | 404.99 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 2.14 Million | 2.05 Million | 1.1 Million | 760.91 Thousand | 558.36 Thousand | 404.99 Thousand |
| Gross Margin | -0.61 | -2.11 | -1.28 | 0.29 | 0.15 | 0.20 |
| EBIT Margin | -4.96 | -13.87 | -10.57 | -1.22 | -2.47 | -1.65 |
| Profit Margin | -5.57 | -20.75 | -17.79 | -1.24 | -2.59 | -1.95 |
| EBITDA | -23.57 Million | -30.63 Million | -33.5 Million | -25.06 Million | -37.01 Million | -22.58 Million |
| Earnings Before Tax Margin | -5.27 | -14.52 | -11.41 | -1.36 | -2.67 | -1.89 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 9062.00 | 6945.00 | 1.45 Million | 4.75 Million | 2.15 Million | 1.5 Million |
| Cost of Revenue | 340.62 Thousand | 441.94 Thousand | 1.89 Million | 7.65 Million | 2.84 Million | 2.04 Million |
| Gross Profit | -331.55 Thousand | -434.99 Thousand | -437.73 Thousand | -2.89 Million | -698.16 Thousand | -536.87 Thousand |
| Operating Expenses | 2.93 Million | 4.32 Million | 5.98 Million | 22.16 Million | 3.64 Million | 4.09 Million |
| Selling, General and Administrative Expenses | 2.51 Million | 3.95 Million | 4.67 Million | - | 2.78 Million | 2.11 Million |
| Research and Development Expenses | 418.51 Thousand | 376.95 Thousand | 1.31 Million | - | 859.84 Thousand | 1.97 Million |
| Other Expenses | 773.76 Thousand | 463.01 Thousand | -113.03 Thousand | -1.87 Million | - | - |
| Cost and Expenses | 3.27 Million | 4.77 Million | 7.88 Million | 29.81 Million | 6.49 Million | 6.13 Million |
| Operating Income | -3.26 Million | -4.76 Million | -6.42 Million | -25.05 Million | -4.34 Million | -4.62 Million |
| Interest Expense | 29.46 Thousand | 46.31 Thousand | - | - | - | - |
| Income Tax Expense | -348.2 Thousand | 1.57 Million | -71.7 Thousand | 2000.00 | 2000.00 | 127.68 Thousand |
| Earnings before Tax | -1.73 Million | -7 Million | -9.01 Million | -26.19 Million | -3.4 Million | -4.27 Million |
| Net Income | -1.38 Million | -8.57 Million | -8.94 Million | -26.47 Million | -3.32 Million | -4.39 Million |
| Earnings Per Share Basic | -0.20 | -3.34 | -4.09 | - | -1.55 | -2.05 |
| Earnings Per Share Diluted | -0.20 | -3.34 | -4.09 | - | -1.55 | -2.05 |
| Weighted Average Shares Outstanding | 7.06 Million | 2.56 Million | 2.18 Million | 2.14 Million | 2.14 Million | 2.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.06 Million | 2.56 Million | 2.18 Million | 2.14 Million | 2.14 Million | 2.14 Million |
| Gross Margin | -36.59 | -62.63 | -0.30 | -0.61 | -0.32 | -0.36 |
| EBIT Margin | -360.07 | -674.43 | -4.35 | - | -1.85 | -2.81 |
| Profit Margin | -153.17 | -1234.57 | -6.15 | -5.57 | -1.55 | -2.92 |
| EBITDA | -3.26 Million | -4.68 Million | -6.32 Million | - | -3.97 Million | -4.23 Million |
| Earnings Before Tax Margin | -360.31 | -686.03 | -4.42 | -5.27 | -2.02 | -3.07 |
4337
3917
ASPO
PANACEABIO
6301
8898